Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.38
(5.63%)
AUD 0.38
(5.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -13.86 Million AUD | -51.52% |
| 2023 | -9.15 Million AUD | 30.5% |
| 2022 | -13.17 Million AUD | -295.04% |
| 2021 | -3.33 Million AUD | 80.07% |
| 2020 | -16.73 Million AUD | 1.81% |
| 2019 | -17.03 Million AUD | -54.74% |
| 2018 | -11.01 Million AUD | -130.71% |
| 2017 | -4.77 Million AUD | -179.39% |
| 2016 | -1.7 Million AUD | -68.39% |
| 2015 | -1.01 Million AUD | 10.3% |
| 2014 | -1.13 Million AUD | 38.75% |
| 2013 | -1.84 Million AUD | -17.76% |
| 2012 | -1.56 Million AUD | -3.18% |
| 2011 | -1.51 Million AUD | 23.58% |
| 2010 | -1.98 Million AUD | 34.66% |
| 2009 | -3.04 Million AUD | -7.72% |
| 2008 | -2.82 Million AUD | 17.32% |
| 2007 | -3.41 Million AUD | -22.08% |
| 2006 | -2.79 Million AUD | -133506.86% |
| 2005 | 2098.00 AUD | 100.22% |
| 2004 | -958 Thousand AUD | 31.52% |
| 2003 | -1.39 Million AUD | 0.78% |
| 2002 | -1.41 Million AUD | -299.43% |
| 2001 | -353 Thousand AUD | 88.87% |
| 2000 | -3.17 Million AUD | -3631.76% |
| 1999 | -85 Thousand AUD | -200.0% |
| 1998 | 85 Thousand AUD | -35.61% |
| 1997 | 132 Thousand AUD | 0.0% |
| 1996 | - AUD | 100.0% |
| 1995 | -234 Thousand AUD | 83.61% |
| 1994 | -1.42 Million AUD | -58.84% |
| 1993 | -899 Thousand AUD | 0.0% |
| 1992 | - AUD | 100.0% |
| 1991 | -61 Thousand AUD | 31.46% |
| 1990 | -89 Thousand AUD | -23.61% |
| 1989 | -72 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -8.4 Million AUD | 0.0% |
| 2024 FY | -13.86 Million AUD | -51.52% |
| 2024 Q2 | -5.46 Million AUD | 0.0% |
| 2023 Q2 | -4.59 Million AUD | 0.0% |
| 2023 FY | -9.15 Million AUD | 30.5% |
| 2023 Q4 | -4.55 Million AUD | 0.0% |
| 2022 Q2 | -6.5 Million AUD | 0.0% |
| 2022 FY | -13.17 Million AUD | -295.04% |
| 2022 Q4 | -6.66 Million AUD | 0.0% |
| 2021 Q4 | -3.99 Million AUD | 0.0% |
| 2021 FY | -3.33 Million AUD | 80.07% |
| 2021 Q2 | 664.12 Thousand AUD | 0.0% |
| 2020 Q2 | -6.99 Million AUD | 0.0% |
| 2020 Q4 | -9.73 Million AUD | 0.0% |
| 2020 FY | -16.73 Million AUD | 1.81% |
| 2019 Q4 | -12.85 Million AUD | 0.0% |
| 2019 FY | -17.03 Million AUD | -54.74% |
| 2019 Q2 | -4.18 Million AUD | 0.0% |
| 2018 FY | -11.01 Million AUD | -130.71% |
| 2018 Q2 | -2.39 Million AUD | 0.0% |
| 2018 Q4 | -8.61 Million AUD | 0.0% |
| 2017 Q4 | -3.52 Million AUD | 0.0% |
| 2017 Q2 | -1.24 Million AUD | 0.0% |
| 2017 FY | -4.77 Million AUD | -179.39% |
| 2016 Q1 | -253.63 Thousand AUD | 0.0% |
| 2016 Q2 | -163.68 Thousand AUD | 35.47% |
| 2016 Q4 | -1.7 Million AUD | -298.04% |
| 2016 FY | -1.7 Million AUD | -68.39% |
| 2016 Q3 | -427.09 Thousand AUD | -160.93% |
| 2015 Q2 | -253.63 Thousand AUD | 10.3% |
| 2015 Q3 | -253.63 Thousand AUD | 0.0% |
| 2015 FY | -1.01 Million AUD | 10.3% |
| 2015 Q4 | - AUD | 100.0% |
| 2015 Q1 | -282.75 Thousand AUD | 0.0% |
| 2014 Q2 | -282.75 Thousand AUD | 38.86% |
| 2014 Q3 | -282.75 Thousand AUD | 0.0% |
| 2014 Q1 | -462.47 Thousand AUD | 0.0% |
| 2014 Q4 | - AUD | 100.0% |
| 2014 FY | -1.13 Million AUD | 38.75% |
| 2013 Q1 | -392 Thousand AUD | 0.0% |
| 2013 Q3 | -462.47 Thousand AUD | 0.0% |
| 2013 FY | -1.84 Million AUD | -17.76% |
| 2013 Q2 | -462.47 Thousand AUD | -17.98% |
| 2013 Q4 | - AUD | 100.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q2 | -392 Thousand AUD | -3.18% |
| 2012 Q3 | -392 Thousand AUD | 0.0% |
| 2012 Q1 | -379.93 Thousand AUD | 0.0% |
| 2012 FY | -1.56 Million AUD | -3.18% |
| 2011 FY | -1.51 Million AUD | 23.58% |
| 2011 Q3 | -379.93 Thousand AUD | 0.0% |
| 2011 Q2 | -379.93 Thousand AUD | 61.48% |
| 2011 Q1 | -986.3 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2010 FY | -1.98 Million AUD | 34.66% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -986.3 Thousand AUD | 0.0% |
| 2010 Q2 | -986.3 Thousand AUD | -29.63% |
| 2010 Q1 | -760.86 Thousand AUD | 0.0% |
| 2009 FY | -3.04 Million AUD | -7.72% |
| 2009 Q1 | -706.31 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q3 | -760.86 Thousand AUD | 0.0% |
| 2009 Q2 | -760.86 Thousand AUD | -7.72% |
| 2008 FY | -2.82 Million AUD | 17.32% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -706.31 Thousand AUD | 0.0% |
| 2008 Q2 | -706.31 Thousand AUD | 17.32% |
| 2008 Q1 | -854.24 Thousand AUD | 0.0% |
| 2007 Q3 | -854.24 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 Q2 | -854.24 Thousand AUD | -22.8% |
| 2007 Q1 | -695.61 Thousand AUD | 0.0% |
| 2007 FY | -3.41 Million AUD | -22.08% |
| 2006 FY | -2.79 Million AUD | -133506.86% |
| 2006 Q3 | -695.61 Thousand AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -695.61 Thousand AUD | -132725.17% |
| 2006 Q1 | 524.50 AUD | 0.0% |
| 2005 Q2 | 524.50 AUD | 100.22% |
| 2005 FY | 2098.00 AUD | 100.22% |
| 2005 Q1 | -239.64 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 524.50 AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 Q2 | -239.64 Thousand AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2004 FY | -958 Thousand AUD | 31.52% |
| 2004 Q3 | -239.64 Thousand AUD | 0.0% |
| 2003 FY | -1.39 Million AUD | 0.78% |
| 2003 Q3 | - AUD | 0.0% |
| 2003 Q1 | -352.48 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 Q2 | - AUD | 100.0% |
| 2002 Q2 | -352.48 Thousand AUD | -299.39% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 FY | -1.41 Million AUD | -299.43% |
| 2002 Q3 | -352.48 Thousand AUD | 0.0% |
| 2002 Q1 | -88.25 Thousand AUD | 0.0% |
| 2001 Q3 | -88.25 Thousand AUD | 0.0% |
| 2001 Q2 | -88.25 Thousand AUD | 88.87% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q1 | -793 Thousand AUD | 0.0% |
| 2001 FY | -353 Thousand AUD | 88.87% |
| 2000 Q2 | -793 Thousand AUD | -3631.76% |
| 2000 FY | -3.17 Million AUD | -3631.76% |
| 2000 Q4 | - AUD | 100.0% |
| 2000 Q3 | -793 Thousand AUD | 0.0% |
| 2000 Q1 | -21.25 Thousand AUD | 0.0% |
| 1999 Q1 | 21.25 Thousand AUD | 0.0% |
| 1999 Q4 | - AUD | 100.0% |
| 1999 FY | -85 Thousand AUD | -200.0% |
| 1999 Q2 | -21.25 Thousand AUD | -200.0% |
| 1999 Q3 | -21.25 Thousand AUD | 0.0% |
| 1998 FY | 85 Thousand AUD | -35.61% |
| 1998 Q1 | 33 Thousand AUD | 0.0% |
| 1998 Q3 | 21.25 Thousand AUD | 0.0% |
| 1998 Q2 | 21.25 Thousand AUD | -35.61% |
| 1998 Q4 | 21.25 Thousand AUD | 0.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 FY | 132 Thousand AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q2 | 33 Thousand AUD | 0.0% |
| 1997 Q3 | 33 Thousand AUD | 0.0% |
| 1996 Q2 | - AUD | 100.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | 100.0% |
| 1996 Q1 | -58.5 Thousand AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1995 FY | -234 Thousand AUD | 83.61% |
| 1995 Q1 | -357 Thousand AUD | 0.0% |
| 1995 Q4 | -58.5 Thousand AUD | 0.0% |
| 1995 Q3 | -58.5 Thousand AUD | 0.0% |
| 1995 Q2 | -58.5 Thousand AUD | 83.61% |
| 1994 Q2 | -357 Thousand AUD | -58.84% |
| 1994 FY | -1.42 Million AUD | -58.84% |
| 1994 Q4 | -357 Thousand AUD | 0.0% |
| 1994 Q3 | -357 Thousand AUD | 0.0% |
| 1994 Q1 | -224.75 Thousand AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 FY | -899 Thousand AUD | 0.0% |
| 1993 Q4 | -224.75 Thousand AUD | 0.0% |
| 1993 Q3 | -224.75 Thousand AUD | 0.0% |
| 1993 Q2 | -224.75 Thousand AUD | 0.0% |
| 1992 Q2 | - AUD | 100.0% |
| 1992 Q1 | -15.25 Thousand AUD | 0.0% |
| 1992 Q3 | - AUD | 0.0% |
| 1992 FY | - AUD | 100.0% |
| 1992 Q4 | - AUD | 0.0% |
| 1991 Q4 | -15.25 Thousand AUD | 0.0% |
| 1991 FY | -61 Thousand AUD | 31.46% |
| 1991 Q1 | -22.25 Thousand AUD | 0.0% |
| 1991 Q2 | -15.25 Thousand AUD | 31.46% |
| 1991 Q3 | -15.25 Thousand AUD | 0.0% |
| 1990 Q1 | -18 Thousand AUD | 0.0% |
| 1990 Q2 | -22.25 Thousand AUD | -23.61% |
| 1990 FY | -89 Thousand AUD | -23.61% |
| 1990 Q3 | -22.25 Thousand AUD | 0.0% |
| 1990 Q4 | -22.25 Thousand AUD | 0.0% |
| 1989 Q3 | -18 Thousand AUD | 0.0% |
| 1989 FY | -72 Thousand AUD | 0.0% |
| 1989 Q4 | -18 Thousand AUD | 0.0% |
| 1989 Q2 | -18 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -157.74% |
| Acrux Limited | -5.8 Million AUD | -139.133% |
| Race Oncology Limited | -13.81 Million AUD | -0.365% |
| Biome Australia Limited | -1.67 Million AUD | -730.421% |
| BTC Health Limited | 1.05 Million AUD | 1414.307% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -10.693% |
| CSL Limited | 2.64 Billion AUD | 100.525% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 67.23% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 138.92% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 299.149% |
| Hexima Limited | -933.87 Thousand AUD | -1385.181% |
| Immutep Limited | -39.89 Million AUD | 65.236% |
| Memphasys Limited | -4.44 Million AUD | -212.239% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 108.83% |
| Noxopharm Limited | -3.57 Million AUD | -287.626% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -68.362% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 71.074% |
| Starpharma Holdings Limited | -8.16 Million AUD | -69.868% |
| Tissue Repair Ltd | -4.13 Million AUD | -235.171% |
| Biotron Limited | -3.43 Million AUD | -303.597% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 27.473% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -855.713% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -475.703% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 62.072% |
| Patrys Limited | -3.53 Million AUD | -291.894% |
| Orthocell Limited | -7.18 Million AUD | -93.146% |
| Imugene Limited | -149.68 Million AUD | 90.734% |
| PYC Therapeutics Limited | -37.72 Million AUD | 63.235% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -117.522% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -42.331% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -58.583% |
| Nanollose Limited | -1.15 Million AUD | -1099.228% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -744.782% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 4378.002% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -207.979% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -384.224% |
| Nyrada Inc. | -1.38 Million AUD | -900.537% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 366.162% |
| Dimerix Limited | -17.07 Million AUD | 18.772% |
| PharmAust Limited | -9.03 Million AUD | -53.556% |
| AnteoTech Limited | -8.88 Million AUD | -56.181% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 76.353% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 21.47% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -303.593% |
| Actinogen Medical Limited | -13.04 Million AUD | -6.328% |
| Immuron Limited | -6.93 Million AUD | -99.939% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -153.121% |